Unilife Corp. (NASDAQ: UNIS; Stock Twits: $UNIS) is a U.S. based developer, manufacturer and supplier of advanced drug delivery systems with state-of-the-art facilities inPennsylvania. Established in 2002, Unilife works with pharmaceutical and biotechnology companies seeking innovative devices for use with their parenteral drugs and vaccines.
Unilife has developed a broad, differentiated proprietary portfolio of its own injectable drug delivery products, including the Unifill® and Unitract® product lines of safety syringes with automatic, operator controlled needle retraction. Unifill represents the world's first prefilled syringe technology integrating safety within the primary drug container. The products are ideally positioned to help pharmaceutical companies maximize the lifecycle of their injectable drugs and enhance patient care. Unifill syringes, together with other devices that are part of the Unilife technology platform, can either be supplied to pharmaceutical customers ready for use, or customized to address the specific requirements of targeted novel drugs.
The Company has announced the release of its investor relations app, now available for free at the App Store(TM) on the iPhone®.
The Unilife app, developed and powered by KCSA Strategic Communications, enables iPhone users to navigate the Company's investor relations materials, and to receive a stock quote and other important stock information. It also features the latest press releases and SEC filings as well as background information, videos and presentations from the Company.
"The Unilife investor relations app for iPhone will help our existing and potential shareholders more easily track our company's updates and stock trading activity. This is increasingly important for those tracking our Company as we look to release a steady flow of positive news this year. All investors are increasingly using mobile technologies to stay up-to-date on the latest company news and market events. By launching the Unilife investor relations app, we are offering our investors a direct path to the most pertinent information surrounding our IR activities, including our latest news releases, SEC filings, audio casts and covering analysts' contact info."
To be added to the Unilife investor email list, please email firstname.lastname@example.org or go to the Unilife website at http://ir.unilife.com/alerts.cfm.